Primary preventive services in patients with systemic lupus erythematosus: Study from a population-based sample in Southeast U.S.

Seminars in Arthritis and Rheumatism

Volumn 43, Issue 2, 2013, Pages 209-216

  Drenkard, Cristina ^a   Rask, Kimberly J ^a,b   Easley, Kirk A ^b   Bao, Gaobin ^a   Lim, S Sam ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Comorbidities; Preventive care; Primary preventive services; Systemic lupus erythematosus

Indexed keywords

ACETYLSALICYLIC ACID; INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

ADULT; AGED; ARTICLE; CANCER SCREENING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GENERAL PRACTITIONER; GEOGRAPHIC DISTRIBUTION; HEALTH INSURANCE; HEALTH STATUS; HEART PROTECTION; HUMAN; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PREVENTIVE HEALTH SERVICE; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK REDUCTION; SMOKING; SYSTEMIC LUPUS ERYTHEMATOSUS; UNITED STATES;

COMORBIDITIES; PREVENTIVE CARE; PRIMARY PREVENTIVE SERVICES; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PRIMARY PREVENTION; QUALITY OF HEALTH CARE; RISK FACTORS; SOUTHEASTERN UNITED STATES;

EID: 84886091637     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2013.04.003     Document Type: Article

References (39)

1. Macinko J., Starfield B., Shi L. The contribution of primary care systems to health outcomes within Organization for Economic Cooperation and Development (OECD) countries, 1970-1998. Health Serv Res 2003, 38(3):831-865. [Epub 2003/06/26].
2. Rand C. The First National Report Card on Quality of Health Care in America. 2006, 〈〉; [accessed 11.20.12]. http://www.rand.org/pubs/research_briefs/RB9053-2/index1.html.
3. Higashi T., Shekelle P.G., Adams J.L., Kamberg C.J., Roth C.P., Solomon D.H., et al. Quality of care is associated with survival in vulnerable older patients. Ann Intern Med 2005, 143(4):274-281. [Epub 2005/08/17].
4. McGlynn E.A., Asch S.M., Adams J., Keesey J., Hicks J., DeCristofaro A., et al. The quality of health care delivered to adults in the United States. N Engl J Med 2003, 348(26):2635-2645. [Epub 2003/06/27].
5. Bernatsky S., Boivin J.F., Joseph L., Manzi S., Ginzler E., Gladman D.D., et al. Mortality in systemic lupus erythematosus. Arthritis Rheum 2006, 54(8):2550-2557.
6. Alarcon G.S., McGwin G., Bartolucci A.A., Roseman J., Lisse J., Fessler B.J., et al. Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual. Arthritis Rheum 2001, 44(12):2797-2806. [Epub 2002/01/05].
7. Cooper G.S., Treadwell E.L., Clair E.W., Gilkeson G.S., Dooley M.A. Sociodemographic associations with early disease damage in patients with systemic lupus erythematosus. Arthritis Rheum 2007, 57(6):993-999.
8. Rhew E.Y., Manzi S.M., Dyer A.R., Kao A.H., Danchenko N., Barinas-Mitchell E., et al. Differences in subclinical cardiovascular disease between African American and Caucasian women with systemic lupus erythematosus. Transl Res 2009, 153(2):51-59. [Epub 2009/01/14].
9. Chaiamnuay S., Bertoli A.M., Roseman J.M., McGwin G., Apte M., Duran S., et al. African-American and Hispanic ethnicities, renal involvement and obesity predispose to hypertension in systemic lupus erythematosus: results from LUMINA, a multiethnic cohort (LUMINAXLV). Ann Rheum Dis 2007, 66(5):618-622.
10. Scalzi L.V., Hollenbeak C.S., Wang L. Racial disparities in age at time of cardiovascular events and cardiovascular-related death in patients with systemic lupus erythematosus. Arthritis Rheum 2010, 62(9):2767-2775. [Epub 2010/05/28].
11. Yazdany J., Tonner C., Trupin L., Panopalis P., Gillis J.Z., Hersh A.O., et al. Provision of preventive health care in systemic lupus erythematosus: data from a large observational cohort study. Arthritis Res Ther 2010, 12(3):R84. [Epub 2010/05/14].
12. Yazdany J., Trupin L., Tonner C., Dudley R.A., Zell J., Panopalis P., et al. Quality of care in systemic lupus erythematosus: application of quality measures to understand gaps in care. J Gen Intern Med 2012, 27(10):1326-1333. [Epub 2012/05/17].
13. Demas K.L., Keenan B.T., Solomon D.H., Yazdany J., Costenbader K.H. Osteoporosis and cardiovascular disease care in systemic lupus erythematosus according to new quality indicators. Semin Arthritis Rheum 2010, 40(3):193-200. [Epub 2010/04/10].
14. Lim S.S., Drenkard C., McCune W.J., Helmick C.G., Gordon C., Deguire P., et al. Population-based lupus registries: advancing our epidemiologic understanding. Arthritis Rheum 2009, 61(10):1462-1466. [Epub 2009/10/01].
15. Lim S.S.B.A., Gordon C., Helmick C.G., Easley K.A., Gaobin B., Shenvi N., et al. The Georgia Lupus Registry: the incidence and prevalence of systemic lupus erythematosus. Arthritis Rheum 2011, 63:S952. [Abstract].
16. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997, 40(9):1725. [Epub 1997/10/27].
17. Centers for Disease Control and Prevention (CDC). About the BRFSS. Turning information into Public Health, 〈〉; [accessed 06.10.12]. http://www.cdc.gov/brfss/about.htm.
18. Nelson D.E., Holtzman D., Bolen J., Stanwyck C.A., Mack K.A. Reliability and validity of measures from the Behavioral Risk Factor Surveillance System (BRFSS). Social Preventive Med 2001, 46(Suppl. 1):S3-42. Epub 2002/02/20.
19. Prevention and Control of Influenza with Vaccines 2010, Centers for Disease Control and Prevention (CDC), Centers for Disease Control and Prevention, 〈http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5908a1.htm?s_cid=rr5908a1_e〉; [accesed 20.11.12].
20. Updated Recommendations for Prevention of Invasive Pneumococcal Disease Among Adults Using the 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) 2010, Centers for Disease Control and Prevention (CDC), Centers for Disease Control and Prevention, 〈http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5934a3.htm〉; [accessed 20.11.12].
21. Centers for Disease Control and Prevention (CDC). Recommended Adult Immunization Schedule-US, 2009, 〈〉; 2009 [accessed 20.11.12]. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5753a6.htm?s_cid=mm5753a6_e.
22. AHRQ. Guide to Clinical Preventive Services, 2010-2011, 〈〉; [accessed 20.11.12]. http://www.ahrq.gov/clinic/pocketgd1011/.
23. Yazdany J., Panopalis P., Gillis J.Z., Schmajuk G., MacLean C.H., Wofsy D., et al. A quality indicator set for systemic lupus erythematosus. Arthritis Rheum 2009, 61(3):370-377. [Epub 2009/02/28].
24. Mosca M., Tani C., Aringer M., Bombardieri S., Boumpas D., Brey R., et al. European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis 2010, 69(7):1269-1274. [Epub 2009/11/07].
25. Wilson E. Probable inference, the law of succession, and statistical inference. J Am Stat Assoc 1927, 22:209-212.
26. Fiscella K., Dressler R., Meldrum S., Holt K. Impact of influenza vaccination disparities on elderly mortality in the United States. Prev Med 2007, 45(1):83-87.
27. Heron M. Deaths: leading causes for 2008. Natl Vital Stat Rep 2012, 60(6):1-94.
28. Ward M.M. Avoidable hospitalizations in patients with systemic lupus erythematosus. Arthritis Rheum 2008, 59(2):162-168.
29. Salmon J.E., Roman M.J. Accelerated atherosclerosis in systemic lupus erythematosus: implications for patient management. Curr Opin Rheumatol 2001, 13(5):341-344.
30. Esdaile J.M., Abrahamowicz M., Grodzicky T., Li Y., Panaritis C., du Berger R., et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001, 44(10):2331. [Epub 2001/10/23].
31. Lockshin M.D., Salmon J.E., Roman M.J. Atherosclerosis and lupus: a work in progress. Arthritis Rheum 2001, 44(10):2215-2217.
32. Nikpour M., Urowitz M.B., Ibanez D., Harvey P.J., Gladman D.D. Importance of cumulative exposure to elevated cholesterol and blood pressure in development of atherosclerotic coronary artery disease in systemic lupus erythematosus: a prospective proof-of-concept cohort study. Arthritis Res Ther 2011, 13(5):R156. [Epub 2011/10/01].
33. Skaggs B.J., Hahn B.H., McMahon M. Accelerated atherosclerosis in patients with SLE-mechanisms and management. Nat Rev Rheumatol 2012, 8(4):214-223. [Epub 2012/02/15].
34. Petri M., Spence D., Bone L.R., Hochberg M.C. Coronary artery disease risk factors in the Johns Hopkins Lupus Cohort: prevalence, recognition by patients, and preventive practices. Medicine (Baltimore) 1992, 71(5):291-302. [Epub 1992/09/01].
35. Morritt Taub L.F. Concordance of provider recommendations with American Diabetes Association's Guidelines. J Am Acad Nurse Pract 2006, 18(3):124-133.
36. Coates R.J., Ogden L., Monroe J.A., Buehler J., Yoon P.W., Collins J.L. Conclusions and future directions for periodic reporting on the use of adult clinical preventive services of public health priority-United States. Morb Mortal Wkly Rep 2012, Suppl. 61:73-78.
37. Rauscher G.H., Johnson T.P., Cho Y.I., Walk J.A. Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive. Oncology 2008, 17(4):748-757. [Epub 2008/04/03].
38. Zimmerman R.K., Raymund M., Janosky J.E., Nowalk M.P., Fine M.J. Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strata. Vaccine 2003, 21(13-14):1486-1491. [Epub 2003/03/05].
39. Fowles J.B., Rosheim K., Fowler E.J., Craft C., Arrichiello L. The validity of self-reported diabetes quality of care measures. Int J Qual Health Care 1999, 11(5):407-412. [Epub 1999/11/24].